ProQR Therapeutics is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa. The company's main product candidates are QR-010, QR-110, and QR-313. Its product pipelineincludes QRX-704, QRX-504, QRX-421, QRX-323 etc.Something looks off?
Open jobs at ProQR Therapeutics